These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 14674951)

  • 1. Delayed-type hypersensitivity to heparins.
    Borch JE; Bindslev-Jensen C
    Allergy; 2004 Jan; 59(1):118-9. PubMed ID: 14674951
    [No Abstract]   [Full Text] [Related]  

  • 2. Autoimmunity: effectiveness of treatments for pregnant women with APS.
    Gelber SE; Salmon JE
    Nat Rev Rheumatol; 2010 Apr; 6(4):187-9. PubMed ID: 20357787
    [No Abstract]   [Full Text] [Related]  

  • 3. Antiphospholipid syndrome in pregnancy.
    Kutteh WH
    Obstet Gynecol; 2002 Dec; 100(6):1354; author reply 1355-6. PubMed ID: 12479178
    [No Abstract]   [Full Text] [Related]  

  • 4. Antiphospholipid syndrome in pregnancy: a randomized, controlled trial of treatment.
    Rai R; Regan L
    Obstet Gynecol; 2002 Dec; 100(6):1354. PubMed ID: 12468184
    [No Abstract]   [Full Text] [Related]  

  • 5. Delayed-type hypersensitivity skin reactions to low molecular weight heparins in a pregnant woman.
    Mora A; Belchi J; Contreras L; Rubio G
    Contact Dermatitis; 2002 Sep; 47(3):177-8. PubMed ID: 12492563
    [No Abstract]   [Full Text] [Related]  

  • 6. [Application of low-molecular-weight heparin during pregnancy and delivery in case of reproductive failure due to antiphospholipid syndrome].
    Karag'ozova Zh; Chernev T; Iankova Z; Baleva M; Dimitrov A
    Akush Ginekol (Sofiia); 2000; 39(3):48-51. PubMed ID: 11187998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary antiphospholipid syndrome in pregnancy: an analysis of outcome in a cohort of 33 women treated with a rigorous protocol.
    Stone S; Hunt BJ; Khamashta MA; Bewley SJ; Nelson-Piercy C
    J Thromb Haemost; 2005 Feb; 3(2):243-5. PubMed ID: 15670028
    [No Abstract]   [Full Text] [Related]  

  • 8. Bleeding complications and antithrombotic treatment in 264 pregnancies in antiphospholipid syndrome.
    Yelnik CM; Lambert M; Drumez E; Le Guern V; Bacri JL; Guerra MM; Laskin CA; Branch DW; Sammaritano LR; Morel N; Guettrot-Imbert G; Launay D; Hachulla E; Hatron PY; Salmon JE; Costedoat-Chalumeau N
    Lupus; 2018 Sep; 27(10):1679-1686. PubMed ID: 30016929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-molecular-weight heparin versus intravenous immunoglobulin for recurrent abortion associated with antiphospholipid antibody syndrome.
    Dendrinos S; Sakkas E; Makrakis E
    Int J Gynaecol Obstet; 2009 Mar; 104(3):223-5. PubMed ID: 19116178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of fetal loss in experimental antiphospholipid syndrome by low-molecular-weight heparin.
    Inbar O; Blank M; Faden D; Tincani A; Lorber M; Shoenfeld Y
    Am J Obstet Gynecol; 1993 Aug; 169(2 Pt 1):423-6. PubMed ID: 8395770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different patterns of cross-reactivity in non-immediate hypersensitivity to heparins: from localized to systemic reactions.
    Poza-Guedes P; González-Pérez R; Canto G
    Contact Dermatitis; 2002 Oct; 47(4):244-5. PubMed ID: 12492535
    [No Abstract]   [Full Text] [Related]  

  • 12. Intravenous immunoglobulin in antiphospholipid syndrome and maternal floor infarction when standard treatment fails: a case report.
    Chang P; Millar D; Tsang P; Lim K; Houlihan E; Stephenson M
    Am J Perinatol; 2006 Feb; 23(2):125-9. PubMed ID: 16506120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody profile of pregnant women with antiphospholipid syndrome and pregnancy outcome after treatment with low dose aspirin and low-weight-molecular heparin.
    Glasnović M; Bosnjak I; Vcev A; Soldo I; Kosuta M; Lenz B; Glasnović-Horvatić E; Soldo-Butković S; Mićunović N
    Coll Antropol; 2007 Mar; 31(1):173-7. PubMed ID: 17598397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical advances of interest in the diagnosis and treatment of patients with antiphospholipid syndrome.
    Rodríguez García JL; Khamashta MA
    Rev Clin Esp (Barc); 2013 Mar; 213(2):108-13. PubMed ID: 22673391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delayed hypersensitivity at the injection sites of a low-molecular-weight heparin.
    Moreau A; Dompmartin A; Esnault P; Michel M; Leroy D
    Contact Dermatitis; 1996 Jan; 34(1):31-4. PubMed ID: 8789222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delayed-type hypersensitivity skin reactions caused by subcutaneous unfractionated and low-molecular-weight heparins: tolerance of a new recombinant hirudin.
    Koch P; Münssinger T; Rupp-John C; Uhl K
    J Am Acad Dermatol; 2000 Apr; 42(4):612-9. PubMed ID: 10727306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of unfractionated and low molecular weight heparin on antiphospholipid antibody binding in vitro.
    Franklin RD; Kutteh WH
    Obstet Gynecol; 2003 Mar; 101(3):455-62. PubMed ID: 12636948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiphospholipid syndrome in obstetrics.
    Kemp M; Thomas W
    Lupus; 2018 Oct; 27(1_suppl):28-31. PubMed ID: 30452326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Successful high-dose low-molecular-weight heparin thromboprophylaxis in pregnant women with antiphospholipid syndrome].
    Boda Z; Schlammadinger A; László P; Lakos G; Kerényi A; Pfliegler G; Rázsó K; Pósán E
    Orv Hetil; 2003 Jun; 144(23):1131-4. PubMed ID: 12858645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis and management of non-criteria obstetric antiphospholipid syndrome.
    Arachchillage DR; Machin SJ; Mackie IJ; Cohen H
    Thromb Haemost; 2015 Jan; 113(1):13-9. PubMed ID: 25318976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.